SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-22-060288
Filing Date
2022-05-13
Accepted
2022-05-13 16:01:19
Documents
4
Period of Report
2022-06-16

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm2215140-1_def14a.htm DEF 14A 859905
2 GRAPHIC lg_gaintherapeutics-4c.jpg GRAPHIC 29589
3 GRAPHIC tm2215140d1-px_01pagebw.jpg GRAPHIC 568774
4 GRAPHIC tm2215140d1-px_02pagebw.jpg GRAPHIC 667103
  Complete submission text file 0001104659-22-060288.txt   2604031
Mailing Address 4800 HAMPDEN LANE SUITE 200 BETHESDA MD 20814
Business Address 4800 HAMPDEN LANE SUITE 200 BETHESDA MD 20814 (301) 500-1556
Gain Therapeutics, Inc. (Filer) CIK: 0001819411 (see all company filings)

IRS No.: 851726310 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-40237 | Film No.: 22922513
SIC: 2834 Pharmaceutical Preparations